Transition Therapeutics, Inc. (TTHI) Reports Q2 Loss of $0.15, Had No Revenue
Transition Therapeutics, Inc. (NASDAQ: TTHI) reported Q2 EPS of ($0.15), versus $0.22 reported last year. Revenue for the quarter came in at $0 , versus $9.4 million reported last year.
For earnings history and earnings-related data on Transition Therapeutics, Inc. (TTHI) click here.
Get immediate access to market moving news and alerts with StreetInsider.com Premium - FREE TRIAL!
For earnings history and earnings-related data on Transition Therapeutics, Inc. (TTHI) click here.
Get immediate access to market moving news and alerts with StreetInsider.com Premium - FREE TRIAL!
You May Also Be Interested In
- UPDATE: Bristow Group (BRS) Reports Better-Than-Expected Q4 Results; Offers FY13 Outlook
- UPDATE: Youku.com (YOKU) Misses Q1 EPS by 1c; Sees Q2 Sales Up 90-100% YoY
- UPDATE: Auriga Starts Teva Pharma (TEVA) at Hold; Sidelined Until New CEO Is Convincing
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
